Sildenafil in primary pulmonary hypertension.

被引：215

作者：

Prasad, S ^{[1
]}

Wilkinson, J ^{[1
]}

Gatzoulis, MA ^{[1
]}

机构：

[1] Royal Brompton Hosp, London SW3 6NP, England

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2000年 / 343卷 / 18期

关键词：

D O I：

10.1056/NEJM200011023431814

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1342 / 1342

页数：1

相关论文

共 4 条

[1] Abrams D, 2000, Heart, V84, pE4, DOI 10.1136/heart.84.2.e4
[2] Sildenafil ameliorates effects of inhaled nitric oxide withdrawal
Atz, AM
Wessel, DL
[J]. ANESTHESIOLOGY, 1999, 91 (01) : 307 - 310
[3] Urinary cGMP concentrations in severe primary pulmonary hypertension
Bogdan, M
Humbert, M
Francoual, J
Claise, C
Duroux, P
Simonneau, G
Lindenbaum, A
[J]. THORAX, 1998, 53 (12) : 1059 - 1062
[4] Cyclic-GMP-binding, cyclic-GMP-specific phosphodiesterase (PDE5) gene expression is regulated during rat pulmonary development
Sanchez, LS
de la Monte, SM
Filippov, G
Jones, RC
Zapol, WM
Bloch, KD
[J]. PEDIATRIC RESEARCH, 1998, 43 (02) : 163 - 168